The Top 25 Firm is expanding its presence in Southern California by acquiring GPW in San Diego, the latest M&A deal since receiving private equity funding.
The One Big Beautiful Bill Act’s presence, like it or not; return of beneficial ownership information; that familiar sense of dread; and other highlights from our favorite tax bloggers.
The company reported $200 million in net losses for the third quarter, but an aggressive and highly successful cost-cutting campaign is helping to stem the downward trend.
In an investor call Thursday, AstraZeneca CEO Pascal Soriot outlined his company’s approach to obesity drug development based on “the medical aspect” of weight loss, including driving down visceral fat.